<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">helmholtzeyeinstitute</journal-id><journal-title-group><journal-title xml:lang="ru">Российский офтальмологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Ophthalmological Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0076</issn><issn pub-type="epub">2587-5760</issn><publisher><publisher-name>Real time Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21516/2072-0076-2020-13-4-99-104</article-id><article-id custom-type="elpub" pub-id-type="custom">helmholtzeyeinstitute-527</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>COVID-19 и проблемы офтальмологии</article-title><trans-title-group xml:lang="en"><trans-title>COVID-19 and problems of ophthalmology</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нероев</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Neroev</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Владимир Владимирович Нероев — академик РАН, профессор, д-р мед. наук, директор</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Vladimir V. Neroev — Academician of the Russian Academy of Sciences, Dr. of Med. Sci., professor, director</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кричевская</surname><given-names>Г. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Krichevskaya</surname><given-names>G. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Галина Исааковна Кричевская — канд. мед. наук, ведущий научный сотрудник отдела иммунологии и вирусологии</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Galina I. Krichevskaya — Cand. of Med. Sci., leading researcher, department of immunology and virology</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><email xlink:type="simple">gkri@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Балацкая</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Balatskaya</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Наталья Владимировна Балацкая — канд. биол. наук, начальник отдела иммунологии и вирусологии</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Natalia V. Balatskaya — Cand. of Biol. Sci., head of the department of immunology and virology</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ глазных болезней им. Гельмгольца» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Helmholtz National Medical Research Center of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>17</day><month>12</month><year>2020</year></pub-date><volume>13</volume><issue>4</issue><fpage>99</fpage><lpage>104</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Нероев В.В., Кричевская Г.И., Балацкая Н.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Нероев В.В., Кричевская Г.И., Балацкая Н.В.</copyright-holder><copyright-holder xml:lang="en">Neroev V.V., Krichevskaya G.I., Balatskaya N.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://roj.igb.ru/jour/article/view/527">https://roj.igb.ru/jour/article/view/527</self-uri><abstract><p>Коронавирусы (CoV) — группа РНК-вирусов, патогенных для животных и человека. До конца XX века СoV человека были известны как возбудители сезонных острых респираторных вирусных инфекций. В начале XXI века возникли 3 пандемии тяжелых респираторных заболеваний с преимущественным поражением нижних отделов дыхательных путей, вызванные новыми СoV: SARS-CoV-возбудителем тяжелого острого респираторного синдрома (SARS) в 2002–2003 гг.; MERS-CoV-возбудителем Ближневосточного респираторного синдрома (MERS) в 2012 г. и SARS-CoV-2-возбудителем коронавирусной болезни-19 (COVID-19), пандемия которой началась в Китае в конце 2019 г. и продолжается в мире до сих пор. В обзоре представлены современные данные о SARS-CoV-2, способах заражения, путях распространения, длительности выявления в организме, роли бессимптомных вирусоносителей в эпидемическом процессе. Описаны преимущества и недостатки основных методов лабораторной диагностики COVID-19: полимеразной цепной реакции для выявления РНК вируса и серологических тестов для выявления IgG-, IgM-специфических антител. Обобщены данные о конъюнктивитах — основном известном в настоящее время глазном симптоме COVID-19. Обсуждается роль слезы и отделяемого из глаза как возможного источника инфекции, а также роль глаза как входных ворот вируса с последующим развитием респираторной инфекции. Подчеркивается высокий профессиональный риск заражения офтальмологов из-за тесного контакта с пациентом во время осмотра. Представлена предложенная в ряде стран современная комплексная система защиты офтальмологов от заражения при обследовании пациентов.</p></abstract><trans-abstract xml:lang="en"><p>Coronaviruses (CoV) are a large group of RNA viruses that are pathogenic to animals and humans. Until the end of the 20th century, human CoV were known as pathogens of seasonal mild respiratory diseases. In the last 20 years new CoVs caused three outbreaks of severe acute respiratory diseases with a predominant lesion of the lower respiratory tract: SARS-CoV — the causative agent of the severe acute respiratory syndrome (SARS) in 2002–2003; MERS-CoV that induced Middle East respiratory syndrome (MERS) in 2012 and SARS-CoV-2 the causative agent of the coronavirus disease-19 (COVID-19), a pandemic of which began in China in late 2019 and is ongoing. The review presents current data on SARS-CoV-2, ways of contagion, transmission routes, detection time in the body, the role of asymptomatic virus carriers in the epidemic process. Advantages and disadvantages of the main laboratory methods of COVID-19 diagnosis are described: polymerase chain reaction (detection of viral RNA) and serological tests (detecting IgG-and IgM-specific antibodies). The data on conjunctivitis, the main currently known ocular symptom of COVID-19, are summarized. The role of the tear and eye discharge as a possible source of infection is discussed, as well as the role of the eye as the entrance gate of the virus with the subsequent development of respiratory infection. The high professional risk of ophthalmologists being infected through close contact with the patient during the examination is outlined. A system of complex protection of ophthalmologists against contagion during examination of patients, proposed in some countries, is presented.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>SARS-CoV-2-инфекция</kwd><kwd>COVID-19</kwd><kwd>ОТ-ПЦР</kwd><kwd>IgG-</kwd><kwd>IgM-антитела к SARS-CoV-2</kwd><kwd>конъюнктивит при COVID-19</kwd><kwd>система профилактики заражения офтальмологов</kwd></kwd-group><kwd-group xml:lang="en"><kwd>SARS-CoV-2</kwd><kwd>COVID-19</kwd><kwd>RT-PCR</kwd><kwd>IgG-</kwd><kwd>IgM-antibodies to SARS-CoV-2</kwd><kwd>conjunctivitis in COVID-19</kwd><kwd>ophthalmological contagion prevention system</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Щелканов М.Ю., Попова А.Ю., Дедков В.Г., Акимкин В.Г., Малеев В.В. История изучения и современная классификация коронавирусов (Nidovirales: Coronaviridae). Инфекция и иммунитет. 2020; 10 (2): 221–46. doi: 10.15789/2220-7619-HOI-1412</mixed-citation><mixed-citation xml:lang="en">Shchelkanov M.Yu., Popova A.Yu., Dedkov V.G., Akimkin V.G., Maleev V.V. History of investigation and current classification of coronaviruses (Nidovirales: Coronaviridae). Russian journal of infection and immunity. 2020; 10 (2): 221–46 (in Russian). https://doi.org/10.15789/2220-7619-HOI-1412</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Guo Y.R., Cao Q.D., Hong Z.S., et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak — an update on the status. Mil. Med. Res. 2020; 7 (1): 1. doi:10.1186/s40779-020-00240-0</mixed-citation><mixed-citation xml:lang="en">Guo Y.R., Cao Q.D., Hong Z.S., et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak — an update on the status. Mil. Med. Res. 2020; 7 (1): 1. doi:10.1186/s40779-020-00240-0</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ge X.Y., Li J.L., Yang X.L., et al. Isolation and characterization of a Bat SARSlike Coronavirus that uses the ACE2 receptor. Version 2. Naturе. 2013 Nov 28; 503 (7477): 535–8. doi: 10.1038/nature12711</mixed-citation><mixed-citation xml:lang="en">Ge X.Y., Li J.L., Yang X.L., et al. Isolation and characterization of a Bat SARSlike Coronavirus that uses the ACE2 receptor. Version 2. Naturе. 2013 Nov 28; 503 (7477): 535–8. doi: 10.1038/nature12711</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lee P.I., Hsueh P.R. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. J. Microbiol. Immunol. Infect. 2020; 53 (3): 365–7. doi:10.1016/j.jmii.2020.02.001</mixed-citation><mixed-citation xml:lang="en">Lee P.I., Hsueh P.R. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. J. Microbiol. Immunol. Infect. 2020; 53 (3): 365–7. doi:10.1016/j.jmii.2020.02.001</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Временные методические рекомендации. Версия 7; 03.06.2020.</mixed-citation><mixed-citation xml:lang="en">Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). The provisional guidelines. Version 7; 03.06.2020 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Tu H., Tu S., Gao S., Shao A., Sheng J. Current epidemiological and clinical features of COVID-19; a global perspective from China. J. Infect. 2020; 81 (1): 1–9. doi: 10.1016/j.jinf.2020.04.011</mixed-citation><mixed-citation xml:lang="en">Tu H., Tu S., Gao S., Shao A., Sheng J. Current epidemiological and clinical features of COVID-19; a global perspective from China. J. Infect. 2020; 81 (1): 1–9. doi: 10.1016/j.jinf.2020.04.011</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Rothe C., Schunk M., Sothmann P., et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N. Engl. J. Med. 2020; 382 (10): 970–1. doi: 10.1056/NEJMc2001468.30</mixed-citation><mixed-citation xml:lang="en">Rothe C., Schunk M., Sothmann P., et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N. Engl. J. Med. 2020; 382 (10): 970–1. doi: 10.1056/NEJMc2001468.30</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zou L., Ruan F., Huang M., et al. SARS-Cov 2 Viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 2020: 382 (12): 1177–9. doi: 10.1056/NEJMc2001737</mixed-citation><mixed-citation xml:lang="en">Zou L., Ruan F., Huang M., et al. SARS-Cov 2 Viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 2020: 382 (12): 1177–9. doi: 10.1056/NEJMc2001737</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Wölfel R., Corman V.M., Guggemos W., et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020; 581 (7809): 465–9. doi:10.1038/s41586-020-2196-x</mixed-citation><mixed-citation xml:lang="en">Wölfel R., Corman V.M., Guggemos W., et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020; 581 (7809): 465–9. doi:10.1038/s41586-020-2196-x</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнов В.С., Тотолян Арег А. Врожденный иммунитет при коронавирусной инфекции. Инфекция и иммунитет. 2020; 10 (2): 259–68. http://dx.doi.org/10.15789/2220-7619-III-1440</mixed-citation><mixed-citation xml:lang="en">Smirnov V.S., Totolian Areg A. Innate immunity in coronavirus infection. Russian journal of infection and immunity; 2020; 10 (2): 259–68 (in Russian). http://dx.doi.org/10.15789/22207619-III-1440</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao S., Lin Q., Ran J., et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China from 2019 to 2020: A datadriven analysis in the early phase of the outbreak. Int. J. Infect. Dis. 2020; 92: 214–7. doi:10.1016/j.ijid.2020.01.050</mixed-citation><mixed-citation xml:lang="en">Zhao S., Lin Q., Ran J., et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China from 2019 to 2020: A datadriven analysis in the early phase of the outbreak. Int. J. Infect. Dis. 2020; 92: 214–7. doi:10.1016/j.ijid.2020.01.050</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Siordia J.A. Jr. Epidemiology and clinical features of COVID-19: A review of current literature. J. Clin. Virol. 2020; 127: 104357. doi:10.1016/j.jcv.2020.104357</mixed-citation><mixed-citation xml:lang="en">Siordia J.A. Jr. Epidemiology and clinical features of COVID-19: A review of current literature. J. Clin. Virol. 2020; 127: 104357. doi:10.1016/j.jcv.2020.104357</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Tan J., Liu S., Zhuang L., et al. Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection. Future Virol. 2020. doi:10.2217/fvl-2020-0087</mixed-citation><mixed-citation xml:lang="en">Tan J., Liu S., Zhuang L., et al. Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection. Future Virol. 2020. doi:10.2217/fvl-2020-0087</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Беляков Н.А., Рассохин В.В., Ястребова Е.Б. Лекция: коронавирусная инфекция COVID-19. Ч. I. Природа вируса, патогенез, клинические проявления. https://www1spbgmu.ru/images/home/covid19/обучение%20врачей</mixed-citation><mixed-citation xml:lang="en">Beljakov N.A., Rassohin V.V., Jastrebova E.B. Lecture: СOVID-19 Coronavirus infection. Part I. Nature of the virus, pathogenesis, clinical manifestations. https://www1spbgmu.ru/images/home/covid19/training%20of%20doctors (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Пащенков М.В., Хаитов М.Р. Иммунный ответ против эпидемических коронавирусов. Иммунология. 2020; 41 (1): 5–18. doi: 10.33029/02064952-2020-41-1-5-18</mixed-citation><mixed-citation xml:lang="en">Pashenkov M.V., Khaitov R.M. Immune response against epidemic coronaviruses. Immunologiya. 2020; 41 (1): 5–18 (in Russian). doi: 10.33029/0206-4952-2020-41-1-5-18</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ai T., Yang Z., Hou H., et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases [published online ahead of print, 2020 Feb 26]. Radiology. 2020; 200642. doi:10.1148/radiol.2020200642</mixed-citation><mixed-citation xml:lang="en">Ai T., Yang Z., Hou H., et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases [published online ahead of print, 2020 Feb 26]. Radiology. 2020; 200642. doi:10.1148/radiol.2020200642</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Fang Y., Zhang H., Xie J., et al. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR [published online ahead of print]. Radiology. 2020; 200432. doi:10.1148/radiol.2020200432</mixed-citation><mixed-citation xml:lang="en">Fang Y., Zhang H., Xie J., et al. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR [published online ahead of print]. Radiology. 2020; 200432. doi:10.1148/radiol.2020200432</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Wu J., Liu J., Li S., et al. Detection and analysis of nucleic acid in various biological samples of COVID-19 patients [published online ahead of print]. Travel. Med. Infect. Dis. 2020; 101673. doi:10.1016/j.tmaid.2020.101673</mixed-citation><mixed-citation xml:lang="en">Wu J., Liu J., Li S., et al. Detection and analysis of nucleic acid in various biological samples of COVID-19 patients [published online ahead of print]. Travel. Med. Infect. Dis. 2020; 101673. doi:10.1016/j.tmaid.2020.101673</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Long Q.X., Liu B.Z., Deng H.J., et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat. Med. 2020; 26 (6): 845–8. doi:10.1038/s41591020-0897-1</mixed-citation><mixed-citation xml:lang="en">Long Q.X., Liu B.Z., Deng H.J., et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat. Med. 2020; 26 (6): 845–8. doi:10.1038/s41591020-0897-1</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Jin Y., Wang M., Zuo Z., et al. Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019. Int. J. Infect. Dis. 2020; 94: 49–52. doi: 10.1016/j.ijid.2020.03.065</mixed-citation><mixed-citation xml:lang="en">Jin Y., Wang M., Zuo Z., et al. Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019. Int. J. Infect. Dis. 2020; 94: 49–52. doi: 10.1016/j.ijid.2020.03.065</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Seah I., Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul. Immunol. Inflamm. 2020; 28 (3): 391–5. doi:10.1080/09273948.2020.1738501</mixed-citation><mixed-citation xml:lang="en">Seah I., Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul. Immunol. Inflamm. 2020; 28 (3): 391–5. doi:10.1080/09273948.2020.1738501</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Belser J.A., Rota P.A., Tumpey T.M. Ocular tropism of respiratory viruses. Microbiol. Mol. Biol. Rev. 2013; 77 (1): 144–56. doi: 10.1128/MMBR.00058-12</mixed-citation><mixed-citation xml:lang="en">Belser J.A., Rota P.A., Tumpey T.M. Ocular tropism of respiratory viruses. Microbiol. Mol. Biol. Rev. 2013; 77 (1): 144–56. doi: 10.1128/MMBR.00058-12</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Coroneo M.T. The eye as the discrete but defensible portal of coronavirus infection [published online ahead of print]. Ocul. Surf. 2020; S15420124(20)30089-6. doi:10.1016/j.jtos.2020.05.011</mixed-citation><mixed-citation xml:lang="en">Coroneo M.T. The eye as the discrete but defensible portal of coronavirus infection [published online ahead of print]. Ocul. Surf. 2020; S15420124(20)30089-6. doi:10.1016/j.jtos.2020.05.011</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou L., Xu Z., Castiglione G.M., et al. ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection. Ocul. Surf. 2020; 18 (4): 537–44. doi:10.1016/j.jtos.2020.06.007</mixed-citation><mixed-citation xml:lang="en">Zhou L., Xu Z., Castiglione G.M., et al. ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection. Ocul. Surf. 2020; 18 (4): 537–44. doi:10.1016/j.jtos.2020.06.007</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Loon S.C., Teoh S.C., Oon L.L., et al. The severe acute respiratory syndrome coronavirus in tears. Br. J. Ophthalmol. 2004; 88 (7): 861–3. doi:10.1136/bjo.2003.035931</mixed-citation><mixed-citation xml:lang="en">Loon S.C., Teoh S.C., Oon L.L., et al. The severe acute respiratory syndrome coronavirus in tears. Br. J. Ophthalmol. 2004; 88 (7): 861–3. doi:10.1136/bjo.2003.035931</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Hu K., Patel J., Patel B.C. Ophthalmic manifestations of Coronavirus (COVID-19). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020.</mixed-citation><mixed-citation xml:lang="en">Hu K., Patel J., Patel B.C. Ophthalmic manifestations of Coronavirus (COVID-19). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Li J.O., Lam D.S.C., Chen Y., Ting D.S.W. Novel Coronavirus disease 2019 (COVID-19): the importance of recognizing possible early ocular manifestation and using protective eyewear. Br. J. Ophthalmol. 2020; 104 (3): 297–8. doi:10.1136/bjophthalmol-2020-315994</mixed-citation><mixed-citation xml:lang="en">Li J.O., Lam D.S.C., Chen Y., Ting D.S.W. Novel Coronavirus disease 2019 (COVID-19): the importance of recognizing possible early ocular manifestation and using protective eyewear. Br. J. Ophthalmol. 2020; 104 (3): 297–8. doi:10.1136/bjophthalmol-2020-315994</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Sun C.B., Wang Y.Y., Liu G.H., Liu Z. Role of the eye in transmitting human coronavirus: what we know and what we do not know. Front. Public Health. 2020; 8: 155. Published 2020 Apr 24. doi:10.3389/fpubh.2020.00155</mixed-citation><mixed-citation xml:lang="en">Sun C.B., Wang Y.Y., Liu G.H., Liu Z. Role of the eye in transmitting human coronavirus: what we know and what we do not know. Front. Public Health. 2020; 8: 155. Published 2020 Apr 24. doi:10.3389/fpubh.2020.00155</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Xie H.T., Jiang S.Y., Xu K.K., et al. SARS-CoV-2 in the ocular surface of COVID-19 patients. Eye Vis. (Lond). 2020; 7: 23. Published 2020 Apr 26. doi:10.1186/s40662-020-00189-0</mixed-citation><mixed-citation xml:lang="en">Xie H.T., Jiang S.Y., Xu K.K., et al. SARS-CoV-2 in the ocular surface of COVID-19 patients. Eye Vis. (Lond). 2020; 7: 23. Published 2020 Apr 26. doi:10.1186/s40662-020-00189-0</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Wu P., Duan F., Luo C., et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020; 138 (5): 575–8. doi:10.1001/jamaophthalmol.2020.1291</mixed-citation><mixed-citation xml:lang="en">Wu P., Duan F., Luo C., et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020; 138 (5): 575–8. doi:10.1001/jamaophthalmol.2020.1291</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Xia J., Tong J., Liu M., Shen Y., Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J. Med. Virol. 2020; 92 (6): 589–94. doi:10.1002/jmv.25725</mixed-citation><mixed-citation xml:lang="en">Xia J., Tong J., Liu M., Shen Y., Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J. Med. Virol. 2020; 92 (6): 589–94. doi:10.1002/jmv.25725</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Cheema M., Aghazadeh H., Nazarali S., et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can. J. Ophthalmol. 2020; S0008-4182(20)30305-7. doi:10.1016/j.jcjo.2020.03.003</mixed-citation><mixed-citation xml:lang="en">Cheema M., Aghazadeh H., Nazarali S., et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can. J. Ophthalmol. 2020; S0008-4182(20)30305-7. doi:10.1016/j.jcjo.2020.03.003</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou Y., Duan C., Zeng Y., et al. Ocular findings and proportion with conjunctival SARS-CoV-2 in COVID-19 patients. Ophthalmology. 2020; 127 (7): 982–3. doi:10.1016/j.ophtha.2020.04.028</mixed-citation><mixed-citation xml:lang="en">Zhou Y., Duan C., Zeng Y., et al. Ocular findings and proportion with conjunctival SARS-CoV-2 in COVID-19 patients. Ophthalmology. 2020; 127 (7): 982–3. doi:10.1016/j.ophtha.2020.04.028</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Guan W.J., Ni Z.Y., Hu Y., et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020; 382 (18): 1708–20. doi:10.1056/NEJMoa2002032</mixed-citation><mixed-citation xml:lang="en">Guan W.J., Ni Z.Y., Hu Y., et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020; 382 (18): 1708–20. doi:10.1056/NEJMoa2002032</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Liang L., Wu P. There may be virus in conjunctival secretion of patients with COVID-19. Acta Ophthalmol. 2020; 98 (3): 223. doi:10.1111/aos.14413</mixed-citation><mixed-citation xml:lang="en">Liang L., Wu P. There may be virus in conjunctival secretion of patients with COVID-19. Acta Ophthalmol. 2020; 98 (3): 223. doi:10.1111/aos.14413</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Aiello F., Gallo Afflitto G., Mancino R. et al. Coronavirus disease 2019 (SARSCoV-2) and colonization of ocular tissues and secretions: a systematic review. Eye (Lond). 2020; 34 (7): 1206–11. doi:10.1038/s41433-020-0926-9</mixed-citation><mixed-citation xml:lang="en">Aiello F., Gallo Afflitto G., Mancino R. et al. Coronavirus disease 2019 (SARSCoV-2) and colonization of ocular tissues and secretions: a systematic review. Eye (Lond). 2020; 34 (7): 1206–11. doi:10.1038/s41433-020-0926-9</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Deng W., Bao L., Gao H., et al. Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in Rhesus macaques. Nature communications. 2020; 11: 4400 https://doi.org/10.1038/s41467-020-18149-6</mixed-citation><mixed-citation xml:lang="en">Deng W., Bao L., Gao H., et al. Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in Rhesus macaques. Nature communications. 2020; 11: 4400 https://doi.org/10.1038/s41467-020-18149-6</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Dockery D.M., Rowe S.G., Murphy M.A., Krzystolik M.G. The ocular manifestations and transmission of COVID-19: recommendations for prevention. J. Emerg. Med. 2020; S0736-4679(20)30398-X. doi:10.1016/j.jemermed.2020.04.06</mixed-citation><mixed-citation xml:lang="en">Dockery D.M., Rowe S.G., Murphy M.A., Krzystolik M.G. The ocular manifestations and transmission of COVID-19: recommendations for prevention. J. Emerg. Med. 2020; S0736-4679(20)30398-X. doi:10.1016/j.jemermed.2020.04.06</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
